(Q44493977)

3 December 2017

title

The verapamil versus amlodipine in nondiabetic nephropathies treated with trandolapril (VVANNTT) study (English)

1 reference

3 December 2017

1 reference

Roberto Boero

1

1 reference

3 December 2017

Cristiana Rollino

2

1 reference

3 December 2017

Carlo Massara

3

1 reference

3 December 2017

Ilario M Berto

4

1 reference

3 December 2017

Paolo Perosa

5

1 reference

3 December 2017

Giuseppe Vagelli

6

1 reference

3 December 2017

Giacomo Lanfranco

7

1 reference

3 December 2017

Francesco Quarello

8

1 reference

3 December 2017

publication date

1 July 2003

1 reference

American Journal of Kidney Diseases

3 December 2017

published in

1 reference

3 December 2017

volume

42

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

67-75

1 reference

Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Are calcium antagonists effective in preventing complications of hypertension and progression of renal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

The effects of an ACE inhibitor and a calcium antagonist on the progression of renal disease: the Nephros Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Dissociation between blood pressure reduction and fall in proteinuria in primary renal disease: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

High proteinuria selectivity index based upon IgM is a strong predictor of poor renal survival in glomerular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

Renal handling of albumin: a critical review of basic concepts and perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2803%2900410-4

7 January 2021

10.1016/S0272-6386(03)00410-4

Identifiers

DOI

1 reference

3 December 2017

1 reference